Drug Guide

Generic Name

Zinc Sulfate

Brand Names Zinc sulfate

Classification

Therapeutic: Mineral and Electrolyte Replacement

Pharmacological: Zinc salt

FDA Approved Indications

  • Zinc deficiency prevention and treatment
  • Acrodermatitis enteropathica (off-label)

Mechanism of Action

Zinc is an essential mineral involved in numerous aspects of cellular metabolism. It functions as a cofactor for numerous enzymes and has roles in immune function, protein synthesis, wound healing, DNA synthesis, and cell division.

Dosage and Administration

Adult: Typically 220 mg (50 mg elemental zinc) once daily, as directed.

Pediatric: Dosing varies based on age; often 10-20 mg elemental zinc daily, under medical supervision.

Geriatric: Similar to adults; dose adjustments based on renal function and dietary intake.

Renal Impairment: Use cautiously; monitor zinc levels and renal function.

Hepatic Impairment: No specific adjustments necessary.

Pharmacokinetics

Absorption: Absorbed in the small intestine, primarily in the jejunum.

Distribution: Widely distributed in body tissues.

Metabolism: Not metabolized; excreted mostly unchanged.

Excretion: Primarily via feces, with some urinary excretion.

Half Life: Approximately 10-14 hours.

Contraindications

  • Hypersensitivity to zinc or any component of the formulation.

Precautions

  • Use with caution in patients with Wilson's disease, as zinc may interfere with copper absorption.
  • Monitor for signs of zinc toxicity in long-term use.

Adverse Reactions - Common

  • Gastrointestinal discomfort (nausea, abdominal pain) (Common)
  • Metallic taste (Common)

Adverse Reactions - Serious

  • Zinc toxicity leading to copper deficiency, anemia, nephrotoxicity (Rare)

Drug-Drug Interactions

  • Chronic renal failure medications, penicillamine, tetracyclines (may interfere with absorption).

Drug-Food Interactions

  • High phytate or fiber content in diet can reduce zinc absorption.

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Assess zinc status if deficiency is suspected; monitor for adverse reactions during therapy.

Diagnoses:

  • Risk for deficiency related to inadequate intake.
  • Ineffective therapeutic regimen management.

Implementation: Administer as prescribed, preferably with food to reduce gastrointestinal discomfort.

Evaluation: Monitor symptoms of deficiency or toxicity, and zinc levels if indicated.

Patient/Family Teaching

  • Take zinc supplements with meals to decrease gastrointestinal upset.
  • Avoid excessive zinc intake; adhere to prescribed doses.
  • Report any adverse reactions or signs of toxicity.

Special Considerations

Black Box Warnings:

  • None established.

Genetic Factors: Patients with Wilson's disease should avoid zinc supplements unless directed by a healthcare provider.

Lab Test Interference: Zinc supplements can interfere with copper and iron laboratory tests.

Overdose Management

Signs/Symptoms: Nausea, vomiting, diarrhea, abdominal pain, dizziness, copper deficiency symptoms.

Treatment: Discontinue zinc, supportive care, chelation therapy if severe toxicity.

Storage and Handling

Storage: Store at room temperature, away from moisture and heat.

Stability: Stable under recommended storage conditions.

This guide is for educational purposes only and is not intended for clinical use.